1Carella C, Mazziotti G, Sorvillo F, et al. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period[J]. Thyroid, 2006, 16(3):295.
2Cappelli C, Gandossi E, Castellano M, et al. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' Disease: a 120 month prospective study [J]. Endocr J, 2007,54 (5):713.
3Ueda M,Ichiyama S,Sugawa H.Thyroid specific T helper cell analysis by ELISPOT assay with thyrotropin receptor (TSH-R) peptides.Peptides,2002,23:103-107.
4Phenekos C,Vryonidou A,Gritzapis AD,et al.Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).Neuroimmunomodulation,2004,11:209-213.
5Crocker IC,Church MK,Newton S,et al.Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by areoallergen-specific T-helper type 2 cell lines.Ann Allergy Asthma Immunol,1998,80:509-516.
6Chen R,Burke TF,Cumberland JE,et al.Glucocorticoids inhibit calcium-and calcineurin-dependent activation of the human IL-4 promoter.J Immunol,2000,164:825-832.
